With CA- based research centers in Richmond and Berkeley, and a recent expansion into Austria (Europe), X-Therma Inc is structured around developing technology for regenerative medicine and organ preservation. The firm has developed cold chain technology via a convergent biopreservation platform, to advance Regenerative Medicine and make available safe and on-demand organs, engineered tissues, cell & gene therapies, vaccines, and beyond to patients in need. The firm's flagship product XT-Thrive®, a DMSO-, Serum-, Protein-free and chemically defined cryopreservation solution directly plugs into the current CMC workflow, resolves bottlenecks in the cell manufacturing process, and enables âoff-the-shelfâ living medicin
